The primary arteriovenous fistula failure-a comparison between diabetic and non-diabetic patients: glycemic control

Baris Afsar1, Rengin Elsurer

  • 1Department of Nephrology, Zonguldak Atatürk State Hospital, Mesrutiyet Mah, Mustafa türkcelik Sok, Büsra Sitesi C Blok, 67100 Zonguldak, Turkey. afsarbrs@yahoo.com

Insights

Poor glycemic control, indicated by HbA1c levels of 7% or higher, significantly increases the risk of primary arteriovenous fistula (AVF) failure in diabetic patients undergoing hemodialysis. This highlights the importance of managing blood sugar to improve AVF outcomes.

Area of Science:

  • Nephrology
  • Vascular Surgery
  • Endocrinology

Background:

  • Diabetes mellitus is a known risk factor for vascular complications.
  • Previous studies have yielded conflicting results regarding the impact of diabetes on primary arteriovenous fistula (AVF) failure.
  • Glycemic control, measured by hemoglobin A1c (HbA1c), is a key indicator of diabetes management.

Purpose of the Study:

  • To investigate the independent association between glycemic control (HbA1c) and primary AVF failure in patients undergoing hemodialysis.
  • To determine if poor glycemic control is a significant predictor of AVF complications before the first successful cannulation.

Main Methods:

  • Retrospective analysis of sociodemographic, clinical, and laboratory data from pre-AVF surgery medical records.
  • Categorization of patients into non-diabetic (Group 1), diabetic with HbA1c <7% (Group 2), and diabetic with HbA1c ≥7% (Group 3).
  • Definition of primary AVF failure as AVF complication before the first successful hemodialysis cannulation.

Main Results:

  • A total of 233 patients were included: 160 non-diabetic and 73 diabetic.
  • Primary AVF failure occurred in 31.8% of all patients.
  • The incidence of primary AVF failure was significantly higher in diabetic patients with HbA1c ≥7% (52.8%) compared to non-diabetic patients (27.5%) and diabetic patients with HbA1c <7% (29.7%).

Conclusions:

  • Poor glycemic control (HbA1c ≥7%) is an independent risk factor for primary AVF failure in diabetic patients.
  • Effective glycemic management may be crucial in preventing AVF failure among diabetic individuals undergoing hemodialysis.
  • Differences in AVF failure rates between diabetic and non-diabetic patients may be partly explained by glycemic control levels.
Abstract

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...